131 related articles for article (PubMed ID: 2862644)
1. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
[TBL] [Abstract][Full Text] [Related]
3. DL-threo-DOPS as a precursor of noradrenaline.
Reches A; Jackson-Lewis V; Fahn S
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
[TBL] [Abstract][Full Text] [Related]
4. The effect of L-erythro-dihydroxyphenylserine injected into the lateral ventricle and the hypothalamus on the locomotor activity.
Noto T; Hashimoto H; Nakao J; Kamimura H; Mori T; Nakajima T
Pharmacol Biochem Behav; 1986 Aug; 25(2):411-4. PubMed ID: 3094040
[TBL] [Abstract][Full Text] [Related]
5. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
[TBL] [Abstract][Full Text] [Related]
6. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
Gibson CJ
Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
Naoi M; Nagatsu T
J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
[TBL] [Abstract][Full Text] [Related]
11. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
[TBL] [Abstract][Full Text] [Related]
13. [Formation of norapinephrine in the rat brain after administration of ((+)-erythro-3,4-dihydroxyphenylserine(author's transl)].
Constantinidis J; Geissbuhler F; Gaillard JM; Aubert C; Hovaguimian TH; Tissot R
Psychopharmacologia; 1975; 41(3):201-9. PubMed ID: 1153609
[TBL] [Abstract][Full Text] [Related]
14. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
15. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
[TBL] [Abstract][Full Text] [Related]
18. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
Semba J; Takahashi R
Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
Hirose A; Sasa M; Ohno Y; Takaori S
Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
[TBL] [Abstract][Full Text] [Related]
20. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
Benkert O; Gluba H; Matussek N
Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
